Effect of Human WEE1 and Stem Cell Factor on Human CD34^＋ Umbilical Cord Blood Cell Damage Induced by Chemotherapeutic Agents

Myelosuppression is one of the major side-effects of most anticancer drugs. To achieve myeloprotection, one bicistronic vector encoding anti-apoptotic protein human WEE l （WEElHu） and proliferation-stimulating stem cell factor （SCF） was generated. In this study, we selected human umbilical cord blood CD34^＋ cells as the in vitro model in an attempt to investigate whether WEEIHu, rather than conventional drug-resistant genes, can be introduced to rescue cells from the damage by chemotherapeutic agents such as cisplatin, adriamycin, mitomycin-c and 5-fluorouracil. Cell viability and cytotoxicity assay, colony-forming units in culture assay and externalization of phospholipid phosphatidylserine analysis showed that the expression of WEElHu and SCF in CD34^＋ cells provided the cells with some protection. These findings suggest that the expression of WEElHu and SCF might rescue CD34^＋ cells from chemotherapyinduced myelosuppression.     

On-line clean-up and screening of oxacillin and cloxacillin in human urine and plasma with a weak ion exchange monolithic column

A weak ion exchange monolithic column prepared by modifying the GMA-MAA-EDMA (glycidyl methacrylate-methacrylic acid-ethylene glycol dimethacrylate) monoliths with ethylenediamine was applied to remove matrix compounds in biological fluid. Using this monolithic column, on-line clean-up and screening of oxacillin and cloxacillin in human urine and plasma samples had been investigated. Chromatography was performed by reversed-phase HPLC on a C(18) column with ultraviolet detection at 225 nm. Results showed that the ion exchange monolithic column could be used for deproteinization and retaining oxacillin and cloxacillin in human urine and plasma, which provided a simple and fast method for assaying drugs in human urine and plasma.     

Nanoparticle-mediated drug delivery and gene therapy

Biomedical application of nanotechnology is a rapidly developing area that raises new prospect in the improvement of diagnosis and treatment of human diseases. The ability to incorporate drugs or genes into a functionalized nanoparticle demonstrates a new era in pharmacotherapy for delivering drugs or genes selectively to tissues or cells. It is envisioned that the transfer of nanoengineering capability into disease therapy will provide constant and concentrated drug delivery to targeted tissues, minimizing systemic side effects and toxicity. We have in this article highlighted the recent state of the art in nanomedicine, focusing particularly on the achievement of nanotechnology in nanoscale drug and gene delivery in vitro and in vivo. In addition, a specific emphasis has been placed on the use of nanotechnology to improve controlled drug release and sustainable drug delivery in solid tumors and on new drug therapies for age-related neurodegenerative disorders.     

基于3种线粒体标记探讨中日沿海角木叶鲽遗传多样性差异

角木叶鲽(Pleuronichthys cornutus)是东亚沿海重要的鲽形目经济鱼类, 为更好地保护和开发利用其种质资源, 有必要全面了解其遗传背景。本研究测定了中国和日本沿海7个群体200尾角木叶鲽线粒体控制区(CR) 5'端、细胞色素b (Cytb)和NADH脱氢酶第二亚基(ND2)基因序列, 比较不同标记在解析遗传多样性和种群结构上的可行性与有效性, 阐明中日沿海角木叶鲽群体间出现遗传分化的分子机制。CR序列分析发现中日沿海7个角木叶鲽群体遗传多样性表现出较高的单倍型多样性(H_d = 0.9699)和较低的核苷酸多样性(π = 0.0061); 各群体间无显著的遗传分化(F_ST = -0.0197-0.0184, P > 0.05); 单倍型网络未显示出明显的地理聚群和谱系结构; 分子方差分析(AMOVA)表明变异主要发生在群体内部(> 99.17%)。进一步通过Cytb和ND2基因分别与CR序列对比分析, 结果表明群体遗传多样性均表现为高H_d (0.9683-0.9829)低π (0.0050-0.0063)模式, 仅有ND2基因分析F_ST值(F_ST = 0.0302, P < 0.05)显示了中国碣石(GDJS)和日本明石(JAP)群体间显著的低水平遗传分化现象。CR、Cytb和ND2的单倍型网络图均无明显的地理聚类和谱系结构, AMOVA分析也显示变异主要来源于群体内(> 98.39%)。种群历史动态分析结果显示, 角木叶鲽可能在第四纪中更新世晚期经历了群体扩张事件, 扩张时间分别为31.93-9.58万年前(CR)、27.53-22.02万年前(Cytb)和26.99-18.75万年前(ND2)。综上所述, 中日沿海的角木叶鲽具有较高遗传多样性, GDJS和JAP群体间存在低度分化; ND2基因比CR和Cytb序列更适于分析角木叶鲽种群遗传结构, 选择多个遗传标记可有效弥补单一标记分析遗传多样性的局限性; 推测冰期两大独立避难所的形成及GDJS和JAP群体距离相隔较远是其发生遗传分化的主要原因。研究结果为中日沿海角木叶鲽渔业资源的种质保护与可持续利用提供了理论依据。     

猎豹(Acinonyx jubatus)肠道微生物多样性及其性别差异研究

[目的]探讨猎豹（Acinonyx jubatus）肠道微生物多样性特征。[方法]通过采集新鲜粪便样品,对9只健康成年野生猎豹（4只雄性,5只雌性）的肠道微生物16S rRNA基因V3-V4区进行高通量测序,对猎豹肠道微生物多样性进行研究。[结果]测序共获得肠道微生物16S rRNA基因V3-V4区有效序列599349条,序列平均长度405 bp。通过以97%的序列相似性进行分类,共获得操作分类单元（OTU） 268个。经序列比对和分类鉴定,这些OTU都属于细菌域,包括10个门,21个纲,35个目,72个科,144个属。其中,丰度最高的5个细菌门是厚壁菌门（Firmicutes,平均占OTU总数的42.29%%）、放线菌门（Actinobacteria,31.54%）、梭杆菌门（Fusobacteroidetes,16.66%）、变形菌门（Proteobacteria,5.30%）和拟杆菌门（Bacteroidetes,4.19%）。拟杆菌门的丰度较低是猎豹肠道微生物的主要特征。丰度最高的5个科依次是红蝽杆菌科（Coriobacteriaceae,31.28%）、消化链球菌科（Peptostreptococcaceae,平均占17.66%）,梭杆菌科（Fusobacteriaceae,15.46%）、毛螺菌科（Lachnospiraceae,12.40%）、梭菌科I（Clostridiaceae_I,6.93%）等。丰度最高的5个属依次是柯林斯氏菌属（Collinsella,30.16%）、梭杆菌属（Fusobacterium,15.46%）、艰难梭菌属（Peptoclostridium,11.46%）、Blautia属（8.28%）和狭窄梭菌属1（Clostridium_sensu_stricto_1,6.39%）。约有2.32%的OTU没有归类到属。群落alpha多样性分析结果显示,猎豹肠道微生物群落Shannon指数为2.93-4.41,Simpson指数为0.72-0.91。通过依据性别进行分组,对雌雄两组之间的alpha多样性比较表明,雄性组的物种和Shannon指数略高于雌性组。Beta多样性分析表明,雌雄两组之间的差异高于各组内部不同个体之间的差异。然而,聚类分析显示,相同性别的猎豹的肠道微生物并没有聚在一起。[结论]本文通过高通量测序技术研究了猎豹肠道微生物多样性特征和性别差异,为猎豹的保护、救护饲养和消化生理学研究提供了基础数据。     

Inhibition of MicroRNA-195 Alleviates Neuropathic Pain by Targeting Patched1 and Inhibiting SHH Signaling Pathway Activation

Trigeminal neuralgia (TN) is a type of chronic neuropathic pain that is caused by peripheral nerve lesions that result from various conditions, including the compression of vessels, tumors and viral infections. MicroRNAs (miRs) are increasingly recognized as potential regulators of neuropathic pain. Previous evidence has demonstrated that miR-195 is involved in neuropathic pain, but the mechanism remains unclear. To investigate the pathophysiological role of miR-195 and Shh signaling in TN, persistent facial pain was induced by infraorbital nerve chronic constriction injury (CCI-IoN), and facial pain responses were evaluated by Von Frey hairs. qPCR and Western blotting were used to determine the relative expression of miR-195 and Patched1, the major receptor of the Sonic Hedgehog (Shh) signaling pathway, in the caudal brain stem at distinct time points after CCI-IoN. Here, we found that the expression of miR-195 was increased in a rat model of CCI-IoN. In contrast, the expression of Patched1 decreased significantly. Luciferase assays confirmed the binding of miR-195 to Patched1. In addition, the overexpression of miR-195 by an intracerebroventricular (i.c.v) administration of LV-miR-195 aggravated facial pain development, and this was reversed by upregulating the expression of Patched1. These results suggest that miR-195 is involved in the development of TN by targeting Patched1 in the Shh signaling pathway, thus regulating extracellular glutamate.